(Omaha, NE) - Nebraska Medicine CEO Dr. James Linder will step down later this summer. Dr. Linder has served Nebraska Medicine in various roles over the past 40 years and has held the position of CEO since August 2018.
Dr. Michael Ash has been unanimously appointed to succeed Dr. Linder as CEO of the nonprofit, private healthcare system. He will officially assume the role later this year.
Kyle Skiermont, PharmD, the current senior vice president of Operations, will be promoted to chief operating officer on July 1st. .
Dr. James Linder is on the left, Dr. Michael Ash on the right.